Literature DB >> 10644354

Proteolytic processing of the astrovirus capsid.

D M Bass1, S Qiu.   

Abstract

To further characterize the nature of proteolytic processing of the astrovirus capsid, we infected Caco-2 cells with a high multiplicity of astrovirus without trypsin in the presence of 5 to 10% fetal calf serum. These infections were characterized by pulse-chase labeling with [35S]Smethionine, electron microscopy, gel electrophoresis of purified viral particles, and analysis of infectivity of such particles with and without added trypsin. Pulse-chase experiments showed that the astrovirus capsid protein was initially translated as an approximately 87-kDa protein. The 87-kDa capsid protein was rapidly converted intracellularly to a 79-kDa form which was found in smaller amounts in the cell supernatant. Purification by differential centrifugation yielded particles that appeared quite similar to trypsin-grown astrovirus particles by negatively stained electron microscopy. These particles were antigenically distinct from trypsin-treated virions as demonstrated by their various reactions with monoclonal antibodies in a solid-phase immunoassay. The purified trypsin-free particles were mainly composed of the 79-kDa capsid protein which was found to have an amino terminus at residue 71 of the entire open reading frame 2 (ORF2) product. The cleavage site was identified in a highly conserved region of the astrovirus ORF2 product. These trypsin-free particles were minimally infectious in cultured Caco-2 cells but became highly infectious (10(5)-fold increase) after trypsin but not chymotrypsin treatment. This trypsin-enhanced infectivity correlated with conversion of the 79-kDa capsid protein to three smaller peptides of approximately 34, 29, and 26 kDa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644354      PMCID: PMC111659          DOI: 10.1128/jvi.74.4.1810-1814.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Prevalence of astrovirus infection among Chilean children with acute gastroenteritis.

Authors:  A Gaggero; M O'Ryan; J S Noel; R I Glass; S S Monroe; N Mamani; V Prado; L F Avendaño
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

2.  Characterization of human serotype 1 astrovirus-neutralizing epitopes.

Authors:  D M Bass; U Upadhyayula
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks.

Authors:  N Blom; J Hansen; D Blaas; S Brunak
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

4.  Capsid protein composition of reference strains and wild isolates of human astroviruses.

Authors:  G Belliot; H Laveran; S S Monroe
Journal:  Virus Res       Date:  1997-05       Impact factor: 3.303

5.  Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses.

Authors:  S S Monroe; B Jiang; S E Stine; M Koopmans; R I Glass
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Serial propagation of astrovirus in tissue culture with the aid of trypsin.

Authors:  T W Lee; J B Kurtz
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

7.  A prospective study of astrovirus diarrhea of infancy in Mexico City.

Authors:  M L Guerrero; J S Noel; D K Mitchell; J J Calva; A L Morrow; J Martínez; G Rosales; F R Velázquez; S S Monroe; R I Glass; L K Pickering; G M Ruiz-Palacios
Journal:  Pediatr Infect Dis J       Date:  1998-08       Impact factor: 2.129

8.  Prevalence of astroviruses in a children's hospital.

Authors:  S Shastri; A M Doane; J Gonzales; U Upadhyayula; D M Bass
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Detection of human astrovirus serotype 1 by the polymerase chain reaction.

Authors:  T O Jonassen; E Kjeldsberg; B Grinde
Journal:  J Virol Methods       Date:  1993-09       Impact factor: 2.014

10.  Population-based prevalence of symptomatic and asymptomatic astrovirus infection in rural Mayan infants.

Authors:  Y Maldonado; M Cantwell; M Old; D Hill; M L Sanchez; L Logan; F Millan-Velasco; J L Valdespino; J Sepulveda; S Matsui
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

View more
  40 in total

1.  Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein.

Authors:  Ernesto Méndez; Teresa Fernández-Luna; Susana López; Martha Méndez-Toss; Carlos F Arias
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Protein products of the open reading frames encoding nonstructural proteins of human astrovirus serotype 8.

Authors:  Ernesto Méndez; M P Elizabeth Salas-Ocampo; María Elena Munguía; Carlos F Arias
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 3.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

4.  Association of the astrovirus structural protein VP90 with membranes plays a role in virus morphogenesis.

Authors:  Ernesto Méndez; Gabriela Aguirre-Crespo; Guadalupe Zavala; Carlos F Arias
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

5.  Crystal structure of the human astrovirus capsid spike.

Authors:  Jinhui Dong; Liping Dong; Ernesto Méndez; Yizhi Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Propagation of Astrovirus VA1, a Neurotropic Human Astrovirus, in Cell Culture.

Authors:  Andrew B Janowski; Irma K Bauer; Lori R Holtz; David Wang
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

7.  Full sequence analysis and characterization of a human astrovirus type 1 isolate from South Korea.

Authors:  Sung-Geun Lee; Lae-Hyung Kang; Weon-Hwa Jheong; Mi-Hwa Oh; Gyu-Cheol Lee; Sujeong Park; Soon-Young Paik
Journal:  J Microbiol       Date:  2013-03-02       Impact factor: 3.422

8.  Isolation of Neutralizing Monoclonal Antibodies to Human Astrovirus and Characterization of Virus Variants That Escape Neutralization.

Authors:  Rafaela Espinosa; Tomás López; Walter A Bogdanoff; Marco A Espinoza; Susana López; Rebecca M DuBois; Carlos F Arias
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

9.  Type I Interferon Response Limits Astrovirus Replication and Protects against Increased Barrier Permeability In Vitro and In Vivo.

Authors:  Shauna A Marvin; C Theodore Huerta; Bridgett Sharp; Pamela Freiden; Troy D Cline; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

10.  Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.

Authors:  Rheba S Bonaparte; Pamela S Hair; Deepa Banthia; Dawn M Marshall; Kenji M Cunnion; Neel K Krishna
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.